
Founded in 2009 with more than 400 employees, Fengcheng provides CDMO services to global pharmaceutical and biotech companies from pre-clinical to commercial stages. With two R&D centers in Tianjin and a production base in Fuxin, the company has accumulated extensive experience across reactions from kilogram to metric-ton scale, applying green technologies to large-scale production while building experience with oligonucleotides and their monomers.

No comments available.
Leave your rating & comment